SEROTONIN AND INSOMNIA

After a long day filled with activities, work, or watching the kids, many of us look forward to that soft fluffy pillow calling us to bed. Unfortunately, some of us discover that once under the sheets we have a tough time relaxing. Too much on our mind? Too much over energy? Physical ailments keeping us awake? The deep uninterrupted REM sleep seems to evade us. 

Our bodies, hearts, and minds need complete rejuvenation time. So why is it so hard for some of us to achieve something so natural? It could be that your serotonin is either too high or too low. Serotonin is critical in nearly every function your body performs.

While serotonin seems to both induce sleep and keep you up, it's a chemical precursor to melatonin, the main hormone involved in sleep. Your body needs serotonin from your pineal gland in order to produce melatonin. The main difference both dopamine and serotonin play a role in your sleep-wake cycle. Low serotonin levels are believed to be linked with depression and insomnia; when levels of serotonin are brought up to normal, sleep falls into place.

Just a few sprays under the tongue before bed will marketably achieve the sleep results you have been longing for. With its six medical use patents, Adapt X.1 is clinically proven to enable the body to balance its own serotonin naturally. 

Arego Life’s ADAPT X.1? includes micronized monocot plant extracts encapsulated in water. We encourage you to try 4-8 sprays a day with a risk-free 60 day money back promise. Follow this link: https://tina.myaregolife.com/

Find out why people all over the world take ADAPT X.1? *These statements have not been evaluated by the Food and Drug Administration. 

As a result, you may experience many benefits such as:

• Improved Function of other Hormones (HGH, Dopamine, Oxytocin)
• Reduced Pain
• Improved Memory 
• Reduced Feelings of Anxiousness
• Reduced Cravings
• Improved Sleep Patterns
• Regulated Digestion
• Improved Organ Functions
• Improved Cardiovascular Health
• Improved Self-Esteem
• Improved Feelings of Love

Following is are the seven, Adapt X.1 medical use patents:

United States Patent & Trademark Office - Patents Assigned to Seroctin Research & Technology, Inc.

Methods for inducing antianxiety and calming effects in animals and humans

Patent number: 7794761

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, or their precursor compounds, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to calm and/or reduce anxiety and related behaviors and states in humans and animals. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human and animal therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Type: Grant - Filed: July 11, 2005 - Date of Patent: September 14, 2010 - Assignee: Seroctin Research & Technology, Inc. - Inventors: Nancy J. Shelby, Mitchell T. Godfrey, Mark J. Rosenfeld

Compounds for use in weight loss and appetite suppression in humans

Patent number: 7541356

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes, and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Type: - Grant Filed: March 28, 2006 - Date of Patent: June 2, 2009 - Assignee: Seroctin Research & Technology, Inc. Inventors: Mark J. Rosenfeld, Scott R. Forsberg 

Compounds for use in weight loss and appetite suppression in humans

Patent number: 7524877

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes, and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. 

Type: Grant - Filed: March 9, 2006 - Date of Patent: April 28, 2009 - Assignee: Seroctin Research & Technology, Inc. Inventors: Mark J. Rosenfeld, Scott R. Forsberg 

Compounds for use in weight loss and appetite suppression in humans

Patent number: 7521467

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemicals synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes, and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Type: Grant - Filed: March 16, 2006 - Date of Patent: April 21, 2009 - Assignee: Seroctin Research & Technology, Inc. Inventors: Mark J. Rosenfeld, Scott R. Forsberg 

Compounds for use in weight loss and appetite suppression in humans

Patent number: 7521468

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes, and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. 

Type: Grant - Filed: March 21, 2006 - Date of Patent: April 21, 2009 - Assignee: Seroctin Research & Technology, Inc. Inventors: Mark J. Rosenfeld, Scott R. Forsberg 

Compounds for use in weight loss and appetite suppression in humans

Patent number: 7507731

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen or another oxygen-containing group, and a C.sub.1-C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes, and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. 

Type: Grant - Filed: March 30, 2006 - Date of Patent: March 24, 2009 - Assignee: Seroctin Research & Technology, Inc. Inventors: Mark J. Rosenfeld, Scott R. Forsberg 

Compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans

Patent number: 6667308

Abstract: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen-containing group, nitrogen- or another oxygen-containing group, and a C.sub.1 -C.sub.4 alkoxy group, obtainable from monocotyledonous plants, animals that eat such plants, or chemical synthesis, have been found to act as an antidepressant or otherwise a treatment for bettering mood, a therapy for improving sexual desire or performance, an adjunctive therapy for achieving weight loss, and an adjunctive therapy for substance abuse and addiction. These compounds, at concentrations suitable for human therapeutic use, may be obtained from plants such as corn in their early growth stages and from parts of animals such as the velvet antler tips of deer and elk. 

Type: Grant - Filed: April 13, 2001 - Date of Patent: December 23, 2003 - Assignee: Seroctin Research & Technology, Inc. - Inventors: Mark J. Rosenfeld, Patricia J. Berger, Norman C. Negus

#serotonin #depression #insomnia #dopamine #arego #pinealgland #anxietyrelief #sleepaidesnatural #plantbasedsleepaides #drugfreesleepaides #balanceserotonin